REFRACTORY SOFT TISSUE SARCOMA
Clinical trials for REFRACTORY SOFT TISSUE SARCOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY SOFT TISSUE SARCOMA trials appear
Sign up with your email to follow new studies for REFRACTORY SOFT TISSUE SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: targeted drug shows promise in early trial
Disease control CompletedThis study tested the drug palbociclib in 23 children and young adults (ages 1-21) whose cancers had come back or stopped responding to treatment. The drug works by blocking certain proteins that help cancer cells grow. The goal was to see if it could shrink tumors or slow the di…
Matched conditions: REFRACTORY SOFT TISSUE SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for kids with tough cancers: targeted pill shows promise
Disease control CompletedThis study tested a drug called tazemetostat in 20 children whose cancers had come back or weren't responding to treatment. The children had specific gene changes (EZH2 or SWI/SNF) in their tumors. The goal was to see if the drug could shrink or control the cancer. This is a dise…
Matched conditions: REFRACTORY SOFT TISSUE SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:01 UTC